VOR BIOPHARMA INC
NASDAQ: VOR (Vor Biopharma Inc.)
Kemas kini terakhir: 22 jam lalu19.26
0.28 (1.48%)
| Penutupan Terdahulu | 18.98 |
| Buka | 18.99 |
| Jumlah Dagangan | 616,581 |
| Purata Dagangan (3B) | 1,180,683 |
| Modal Pasaran | 1,043,619,968 |
| Harga / Buku (P/B) | 0.660 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 14 Aug 2026 |
| EPS Cair (TTM) | -1.51 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 46.59% |
| Nisbah Semasa (MRQ) | 3.88 |
| Aliran Tunai Operasi (OCF TTM) | -100.26 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -61.85 M |
| Pulangan Atas Aset (ROA TTM) | -55.25% |
| Pulangan Atas Ekuiti (ROE TTM) | -125.43% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Vor Biopharma Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.5 |
| Purata | -0.63 |
|
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 43.00% |
| % Dimiliki oleh Institusi | 46.77% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Frazier Life Sciences Management, L.P. | 31 Mar 2026 | 2,543,939 |
| Paradigm Biocapital Advisors Lp | 31 Mar 2026 | 1,750,000 |
| Nextbio Capital Management Lp | 31 Mar 2026 | 999,967 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | 17.34 | -213 | -3,693 |
| Jumlah Keseluruhan Kuantiti Bersih | -213 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -3,693 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 17.34 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 16 Jul 2026 | Jual (-) | 213 | 17.34 | 3,693 | |
| RA CAPITAL MANAGEMENT, L.P. | 16 Jul 2026 | Pelaksanaan pilihan | 2,100,000 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |